Showing results (71-80 of 272) with videos related to

Sort By:
Pageof 28
Cancer|January 13, 2004
Phase II study of pentostatin in advanced T-cell lymphoid malignancies: update of an M.D. Anderson Cancer Center seriesApostolia-Maria Tsimberidou, Francis Giles, Madeleine Duvic, et al.
Journal of Gastrointestinal Oncology|November 30, 2017
Correlation of tumor mutational burden and treatment outcomes in patients with colorectal cancerSachin G Pai, Benedito A Carneiro, Young Kwang Chae, et al.
The Prostate|July 29, 2014
Nanomechanical biomarkers of single circulating tumor cells for detection of castration resistant prostate cancerPawel Osmulski, Devalingam Mahalingam, Maria E Gaczynska, et al.
Annals of Internal Medicine|December 21, 2006
New insights into the pathophysiology of chronic myeloid leukemia and imatinib resistanceHagop M Kantarjian, Moshe Talpaz, Francis Giles, et al.
Expert Opinion on Investigational Drugs|November 18, 2008
Deforolimus (AP23573) a novel mTOR inhibitor in clinical developmentMonica Mita, Kamalesh Sankhala, Issam Abdel-Karim, et al.
Oncotarget|May 19, 2018
Systematic review and meta-analysis of selected toxicities of approved ALK inhibitors in metastatic non-small cell lung cancerRubens Barros Costa, Ricardo L B Costa, Sarah M Talamantes, et al.
Cancer Treatment Reviews|January 21, 2017
Targeting Epidermal Growth Factor Receptor in triple negative breast cancer: New discoveries and practical insights for drug developmentRicardo Costa, Ami N Shah, Cesar A Santa-Maria, et al.
Molecular & Cellular Proteomics : MCP|January 4, 2012
Kinetics in signal transduction pathways involving promiscuous oligomerizing receptors can be determined by receptor specificity: apoptosis induction by TRAILEva Szegezdi, Almer M van der Sloot, Devalingam Mahalingam, et al.
Leukemia & Lymphoma|April 11, 2015
Novel therapies for myelofibrosisBrady L Stein, Francisco Cervantes, Francis Giles, et al.
Pageof 28